Bartlett & Co Wealth Management’s Halozyme HALO Stock Holding History

Bartlett & Co Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$324K	Buy	+4,144	New	+$283K	﹤0.01%	407

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Bartlett & Co Wealth Management's HALO Position: Q2 2026 in Review

Bartlett & Co Wealth Management opened a new position in Halozyme (HALO) in Q2 2026: 4,144 shares worth $324K. The stake represents ﹤0.01% of the portfolio and ranks #407 among its holdings.

668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Bartlett & Co Wealth Management held 4,144 shares of Halozyme worth $324K as of Q2 2026.
Halozyme was a new Bartlett & Co Wealth Management position in Q2 2026.
Halozyme made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #407 holding.
668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.